The novel receptor TRAIL-R4 induces NF-kappaB and protects against TRAIL-mediated apoptosis, yet retains an incomplete death domain.
Тип публикации: Journal Article
Дата публикации: 1997-12-01
scimago Q1
wos Q1
БС1
SJR: 12.163
CiteScore: 40.8
Impact factor: 26.3
ISSN: 10747613, 10974180
PubMed ID:
9430226
Infectious Diseases
Immunology
Immunology and Allergy
Найдено
Ничего не найдено, попробуйте изменить настройки фильтра.
Найдено
Ничего не найдено, попробуйте изменить настройки фильтра.
Топ-30
Журналы
|
5
10
15
20
25
30
|
|
|
Journal of Biological Chemistry
29 публикаций, 4.36%
|
|
|
Journal of Immunology
29 публикаций, 4.36%
|
|
|
Oncogene
21 публикация, 3.16%
|
|
|
Cancer Research
15 публикаций, 2.26%
|
|
|
Vitamins and Hormones
15 публикаций, 2.26%
|
|
|
Cell Death and Differentiation
14 публикаций, 2.11%
|
|
|
Blood
14 публикаций, 2.11%
|
|
|
Biochemical and Biophysical Research Communications
10 публикаций, 1.5%
|
|
|
Cancers
10 публикаций, 1.5%
|
|
|
International Journal of Cancer
10 публикаций, 1.5%
|
|
|
British Journal of Cancer
9 публикаций, 1.35%
|
|
|
Cancer Letters
8 публикаций, 1.2%
|
|
|
Molecular Cancer Therapeutics
8 публикаций, 1.2%
|
|
|
BMC Cancer
7 публикаций, 1.05%
|
|
|
British Journal of Haematology
7 публикаций, 1.05%
|
|
|
Journal of Cellular Biochemistry
7 публикаций, 1.05%
|
|
|
Oncotarget
6 публикаций, 0.9%
|
|
|
International Journal of Molecular Sciences
6 публикаций, 0.9%
|
|
|
Apoptosis : an international journal on programmed cell death
6 публикаций, 0.9%
|
|
|
Cancer Gene Therapy
6 публикаций, 0.9%
|
|
|
FEBS Letters
6 публикаций, 0.9%
|
|
|
Journal of Experimental Medicine
6 публикаций, 0.9%
|
|
|
Laboratory Investigation
5 публикаций, 0.75%
|
|
|
Hepatology
5 публикаций, 0.75%
|
|
|
Leukemia
5 публикаций, 0.75%
|
|
|
Journal of Cellular Physiology
5 публикаций, 0.75%
|
|
|
Clinical Cancer Research
5 публикаций, 0.75%
|
|
|
Journal of Neuroimmunology
4 публикации, 0.6%
|
|
|
Human Gene Therapy
4 публикации, 0.6%
|
|
|
5
10
15
20
25
30
|
Издатели
|
20
40
60
80
100
120
140
160
|
|
|
Springer Nature
152 публикации, 22.86%
|
|
|
Elsevier
139 публикаций, 20.9%
|
|
|
Wiley
91 публикация, 13.68%
|
|
|
American Association for Cancer Research (AACR)
30 публикаций, 4.51%
|
|
|
American Society for Biochemistry and Molecular Biology
29 публикаций, 4.36%
|
|
|
The American Association of Immunologists
29 публикаций, 4.36%
|
|
|
MDPI
27 публикаций, 4.06%
|
|
|
Taylor & Francis
15 публикаций, 2.26%
|
|
|
American Society of Hematology
14 публикаций, 2.11%
|
|
|
Ovid Technologies (Wolters Kluwer Health)
10 публикаций, 1.5%
|
|
|
Frontiers Media S.A.
8 публикаций, 1.2%
|
|
|
American Society for Microbiology
8 публикаций, 1.2%
|
|
|
Oxford University Press
8 публикаций, 1.2%
|
|
|
Mary Ann Liebert
7 публикаций, 1.05%
|
|
|
Impact Journals
6 публикаций, 0.9%
|
|
|
Hindawi Limited
6 публикаций, 0.9%
|
|
|
Rockefeller University Press
6 публикаций, 0.9%
|
|
|
Baishideng Publishing Group
4 публикации, 0.6%
|
|
|
Public Library of Science (PLoS)
4 публикации, 0.6%
|
|
|
Cold Spring Harbor Laboratory
4 публикации, 0.6%
|
|
|
Portland Press
3 публикации, 0.45%
|
|
|
American Society for Clinical Investigation
2 публикации, 0.3%
|
|
|
Spandidos Publications
2 публикации, 0.3%
|
|
|
SAGE
2 публикации, 0.3%
|
|
|
Federation of American Societies for Experimental Biology (FASEB)
2 публикации, 0.3%
|
|
|
American Chemical Society (ACS)
2 публикации, 0.3%
|
|
|
Royal Society of Chemistry (RSC)
2 публикации, 0.3%
|
|
|
Pleiades Publishing
2 публикации, 0.3%
|
|
|
Japanese Society of Animal Reproduction
2 публикации, 0.3%
|
|
|
20
40
60
80
100
120
140
160
|
- Мы не учитываем публикации, у которых нет DOI.
- Статистика публикаций обновляется еженедельно.
Вы ученый?
Создайте профиль, чтобы получать персональные рекомендации коллег, конференций и новых статей.
Метрики
665
Всего цитирований:
665
Цитирований c 2024:
15
(2.25%)
Цитировать
ГОСТ |
RIS |
BibTex |
MLA
Цитировать
ГОСТ
Скопировать
Degli-Esposti M. A. et al. The novel receptor TRAIL-R4 induces NF-kappaB and protects against TRAIL-mediated apoptosis, yet retains an incomplete death domain. // Immunity. 1997. Vol. 7. No. 6. pp. 813-820.
ГОСТ со всеми авторами (до 50)
Скопировать
Degli-Esposti M. A., Dougall W. C., Smolak P. J., Waugh J. Y., Smith C. A., Goodwin R. G. The novel receptor TRAIL-R4 induces NF-kappaB and protects against TRAIL-mediated apoptosis, yet retains an incomplete death domain. // Immunity. 1997. Vol. 7. No. 6. pp. 813-820.
Цитировать
RIS
Скопировать
TY - JOUR
DO - 10.1016/S1074-7613(00)80399-4
UR - https://doi.org/10.1016/S1074-7613(00)80399-4
TI - The novel receptor TRAIL-R4 induces NF-kappaB and protects against TRAIL-mediated apoptosis, yet retains an incomplete death domain.
T2 - Immunity
AU - Degli-Esposti, Mariapia A
AU - Dougall, William C
AU - Smolak, Pamela J
AU - Waugh, Jennifer Y.
AU - Smith, Craig A.
AU - Goodwin, Raymond G.
PY - 1997
DA - 1997/12/01
PB - Elsevier
SP - 813-820
IS - 6
VL - 7
PMID - 9430226
SN - 1074-7613
SN - 1097-4180
ER -
Цитировать
BibTex (до 50 авторов)
Скопировать
@article{1997_Degli-Esposti,
author = {Mariapia A Degli-Esposti and William C Dougall and Pamela J Smolak and Jennifer Y. Waugh and Craig A. Smith and Raymond G. Goodwin},
title = {The novel receptor TRAIL-R4 induces NF-kappaB and protects against TRAIL-mediated apoptosis, yet retains an incomplete death domain.},
journal = {Immunity},
year = {1997},
volume = {7},
publisher = {Elsevier},
month = {dec},
url = {https://doi.org/10.1016/S1074-7613(00)80399-4},
number = {6},
pages = {813--820},
doi = {10.1016/S1074-7613(00)80399-4}
}
Цитировать
MLA
Скопировать
Degli-Esposti, Mariapia A., et al. “The novel receptor TRAIL-R4 induces NF-kappaB and protects against TRAIL-mediated apoptosis, yet retains an incomplete death domain..” Immunity, vol. 7, no. 6, Dec. 1997, pp. 813-820. https://doi.org/10.1016/S1074-7613(00)80399-4.